AI-Driven Discovery of Nanostructures That Disrupt Antibiotic-Resistant Biofilms

machine learning

Antibiotic-resistant biofilms pose a significant challenge to modern healthcare, complicating the treatment of infections associated with chronic diseases and medical devices. These biofilms provide bacteria with a protective barrier that shields them from antibiotics and immune responses, making infections difficult to treat. The development of novel therapeutic strategies to disrupt these biofilms is crucial in overcoming antibiotic resistance. Nanotechnology, particularly engineered nanostructures, holds great promise for addressing this challenge. Recent advancements in artificial intelligence (AI) have enabled the acceleration of the discovery and optimization of nanomaterials for biofilm disruption. This article explores how AI can be applied to the design, synthesis, and testing of nanostructures that target antibiotic-resistant biofilms, offering new insights into the development of more effective treatments.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.